298.55
Medpace Holdings Inc stock is traded at $298.55, with a volume of 399.58K.
It is down -1.43% in the last 24 hours and down -8.00% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$302.88
Open:
$300
24h Volume:
399.58K
Relative Volume:
0.87
Market Cap:
$8.31B
Revenue:
$2.07B
Net Income/Loss:
$365.67M
P/E Ratio:
26.14
EPS:
11.42
Net Cash Flow:
$535.65M
1W Performance:
+0.77%
1M Performance:
-8.00%
6M Performance:
-9.59%
1Y Performance:
-23.40%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MEDP
Medpace Holdings Inc
|
298.55 | 8.31B | 2.07B | 365.67M | 535.65M | 11.42 |
![]()
TMO
Thermo Fisher Scientific Inc
|
424.24 | 159.25B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
197.14 | 132.37B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
437.44 | 32.95B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
106.28 | 28.58B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
150.28 | 24.90B | 15.41B | 1.37B | 2.11B | 7.50 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
Mar-24-25 | Initiated | Leerink Partners | Market Perform |
Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Sep-27-24 | Downgrade | UBS | Buy → Neutral |
Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
Aug-01-24 | Initiated | Truist | Hold |
May-29-24 | Initiated | TD Cowen | Buy |
May-28-24 | Initiated | Mizuho | Buy |
Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
Mar-18-24 | Initiated | Deutsche Bank | Hold |
Feb-15-24 | Upgrade | UBS | Neutral → Buy |
Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
Oct-27-22 | Upgrade | UBS | Sell → Neutral |
Sep-07-22 | Initiated | UBS | Sell |
May-24-22 | Initiated | Guggenheim | Neutral |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Oct-02-20 | Upgrade | Truist | Hold → Buy |
Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
Sep-17-18 | Initiated | SunTrust | Hold |
Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-29-17 | Initiated | Raymond James | Mkt Perform |
Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Medpace (MEDP) Faces Earnings Volatility Amid Tariff Concerns - GuruFocus
Medpace drops despite Q1 beat amid disappointing performance metrics - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus
Medpace to increase size of stock buyback program by $1B - MSN
William Blair Downgrades Medpace Holdings (BMV:MEDP) - Nasdaq
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript - Insider Monkey
Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outlook | MEDP Stock News - GuruFocus
Medpace Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive ... - Yahoo Finance
Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive Challenges - GuruFocus
Medpace Holdings Reports Strong Q1 2025 Results - TipRanks
Medpace Holdings Inc. Earnings Call: Mixed Sentiments and Modest Growth - TipRanks
Medpace Holdings Stock Falls 11.2% Post Q1 2025 EarningsNews and Statistics - IndexBox
Medpace Holdings, Inc. SEC 10-Q Report - TradingView
Medpace (MEDP) Reports Revenue Growth Despite Challenges - GuruFocus
Medpace (MEDP) Stock Declines on Earnings Report - GuruFocus
Medpace (MEDP) Expands Share Buyback Program by $1 Billion - GuruFocus
Medpace Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:MEDP) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - Yahoo Finance
Medpace stock rating cut to Market Perform by William Blair - Investing.com South Africa
Medpace (MEDP) Disappoints with Key Metrics Despite Strong Financials - GuruFocus
Medpace stock drops despite Q1 beat (MEDP:NASDAQ) - Seeking Alpha
TD Cowen holds Medpace stock rating, maintains $328 target - Investing.com
Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified - MSN
Medpace (MEDP) Exceeds Q1 Earnings Expectations - GuruFocus
Medpace (MEDP) Surpasses Revenue and EPS Expectations in Q1 2025 - GuruFocus
TD Cowen holds Medpace stock rating, maintains $328 target By Investing.com - Investing.com Canada
Earnings call transcript: Medpace Q1 2025 beats forecasts, shares drop - Investing.com
Earnings call transcript: Medpace Q1 2025 beats forecasts, shares drop By Investing.com - Investing.com UK
S&P 500 Futures Climb in Premarket Trading; Northrop Grumman, Medpace Holdings Lag - Barron's
Medpace: Q1 Earnings Snapshot - MySA
Medpace Holdings’ revenue increases 9.3% to USD 558.6M in Q1 2025 - Medical Buyer
Medpace Holdings earnings beat by $0.62, revenue topped estimates - Investing.com Canada
Medpace Holdings Stock Dips Amid Market Challenges - TipRanks
Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Medpace Holdings Reports Q1 Earnings, Shares Move Lower - Benzinga
Medpace Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Medpace (MEDP) Exceeds Q1 Expectations, Projects 2025 Growth - GuruFocus
Medpace Holdings Exceeds Q1 Revenue Forecasts and Adjusts Full-Year OutlookNews and Statistics - IndexBox
Medpace Q1 Earnings, Revenue Rise; Issues Guidance - marketscreener.com
Medpace shares fall as Q2 bookings miss expectations - Investing.com Australia
Medpace shares fall as Q2 bookings miss expectations By Investing.com - Investing.com India
Medpace Holdings, Inc. Reports First Quarter 2025 Results | MEDP Stock News - GuruFocus
Medpace Holdings Inc Surpasses Q1 2025 Estimates with $3.67 EPS and $558.6 Million Revenue - GuruFocus
Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops - Yahoo Finance
Medpace (NASDAQ:MEDP) Beats Expectations In Strong Q1 But Stock Drops - Barchart.com
Earnings Flash (MEDP) Medpace Holdings Reports Q1 Revenue $558.6M, vs. FactSet Est of $526.3M - marketscreener.com
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medpace Holdings Inc Stock (MEDP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Troendle August J. | CEO |
Mar 07 '25 |
Option Exercise |
68.62 |
356,446 |
24,458,835 |
1,011,102 |
EWALD STEPHEN P | General Counsel & Corp. Secy. |
Feb 27 '25 |
Buy |
326.11 |
2 |
652 |
13,343 |
Carley Brian T | Director |
Feb 24 '25 |
Option Exercise |
42.62 |
8,127 |
346,373 |
30,035 |
Carley Brian T | Director |
Feb 24 '25 |
Sale |
345.59 |
4,003 |
1,383,397 |
26,032 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):